Rossana Casaretti
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
Journal: Frontiers in oncology
Published: October 30, 2022
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
Journal: ESMO open
Published: October 10, 2022
Role of shrinkage in esophageal-gastric junction cancer.
Journal: Clinical case reports
Published: August 15, 2022
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 08, 2022
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Journal: Therapeutic advances in medical oncology
Published: March 27, 2020
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
Journal: BMC cancer
Published: February 19, 2019
Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors.
Journal: Oncotarget
Published: April 26, 2018
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Journal: Frontiers in pharmacology
Published: January 19, 2018
Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.
Journal: Oncotarget
Published: October 11, 2017
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Journal: Current cancer drug targets
Published: January 11, 2016
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Journal: Oncology
Published: November 13, 2015
Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy.
Journal: Cancer immunology research
Published: July 27, 2015
Last Updated: 09/26/2026